Arrayit has announced the sale of a system to the Center of Excellence for Nucleic Acid-Based Technologies (CENAT) in Poznan, Poland.
The Arrayit NanoPrint Microarrayer will be used by CENAT for scientific and medical collaborations, including myeloid leukemia cancer analysis.
Dr Luiza Handschuh, CENAT laboratory director, said: 'Arrayit's system offers us the ability to make high-quality microarrays of all types that will greatly enhance cancer research by enabling quantitative DNA, RNA and protein analysis.'
